Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma

Cancer immunotherapy has made unprecedented breakthrough in the fields of chimeric antigen receptor-redirected T (CAR T) cell therapy and immune modulation. Combination of CAR modification and the disruption of endogenous inhibitory immune checkpoints on T cells represent a promising immunotherapeut...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Xingliang, Jiang, Hua, Shi, Bizhi, Zhou, Min, Zhang, Honghong, Shi, Zhimin, Du, Guoxiu, Luo, Hong, Wu, Xiuqi, Wang, Yi, Sun, Ruixin, Li, Zonghai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174208/
https://www.ncbi.nlm.nih.gov/pubmed/30327605
http://dx.doi.org/10.3389/fphar.2018.01118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174208/
https://www.ncbi.nlm.nih.gov/pubmed/30327605
http://dx.doi.org/10.3389/fphar.2018.01118

Ejemplares similares